NCT01625104

Brief Summary

The primary objective of this study is to assess whether an aggressive quality improvement intervention strategy will decrease time from hospital presentation to first balloon inflation in non-transfer patients with acute ST segment elevation MI (STEMI) treated with primary percutaneous coronary intervention (PCI). Twelve hospitals in Michigan were randomized to either aggressive intervention or control. The intervention consisted of Grand Rounds at each hospital, sharing of best practices, and coordinating center staff working closely with staff at each intervention hospital to discuss solutions to barriers to rapid treatment for STEMI patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
882

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2003

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2003

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2006

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2006

Completed
5.6 years until next milestone

First Submitted

Initial submission to the registry

June 19, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 21, 2012

Completed
5.5 years until next milestone

Results Posted

Study results publicly available

December 15, 2017

Completed
Last Updated

December 15, 2017

Status Verified

May 1, 2017

Enrollment Period

2.4 years

First QC Date

June 19, 2012

Results QC Date

December 10, 2013

Last Update Submit

May 15, 2017

Conditions

Keywords

Myocardial InfarctionTime to TreatmentDoor to Balloon Time

Outcome Measures

Primary Outcomes (1)

  • Percentage of Sites With Reduction in Door to Balloon Time

    Arrival time in Emergency Department to first balloon inflation in the coronary artery. Any reduction in median Door to Balloon Time from baseline to follow-up was counted as reduction in time

    Arrival to balloon inflation, measured in minutes (generally less than 120 mins)

Study Arms (2)

Group 1: Aggressive Intervention Strategy

EXPERIMENTAL

Hospitals were randomized to an aggressive intervention strategy or to "business as usual". The hospitals randomized to the aggressive intervention strategy underwent the following: 1. Grand Rounds conducted by physician and nurse from the Coordinating Center. This included a formal presentation on the evidence supporting rapid time to treatment in STEMI patients and evidence based strategies for reducing treatment delays. 2. Discussion with staff regarding perceived barriers to treatment and suggestions/ideas for strategies to overcome these barriers 3. Follow-up monthly phone conferences to continue to discuss strategies and ideas sharing 4. Written plan from sites detailing plans to change processes of care.

Other: Agressive Intervention Process Improvement Strategies

Group 2: Control Strategy

PLACEBO COMPARATOR

Hospitals randomized to the control group were instructed to conduct "business as usual".

Other: Non Intervention

Interventions

Business as usual

Group 2: Control Strategy
Group 1: Aggressive Intervention Strategy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Acute ST segment myocardial infarction, non transfer patients, with symptom onset to balloon time less than or equal to 24 hours.

You may not qualify if:

  • Patients transferred from one facility to another,
  • non ST segment myocardial infarction patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

ST Elevation Myocardial InfarctionMyocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Results Point of Contact

Title
Eva Kline-Rogers MS, RN
Organization
University of Michigan

Study Officials

  • Mauro Moscucci, M.D.

    University of Michigan

    PRINCIPAL INVESTIGATOR
  • Eva M Kline-Rogers, MS, RN

    University of Michigan

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Coordinator

Study Record Dates

First Submitted

June 19, 2012

First Posted

June 21, 2012

Study Start

September 1, 2003

Primary Completion

February 1, 2006

Study Completion

December 1, 2006

Last Updated

December 15, 2017

Results First Posted

December 15, 2017

Record last verified: 2017-05

Locations